Epstein-Barr virus Rta-mediated transactivation of p21 and 14-3-3σ arrests cells at the G1/s transition by reducing cyclin E/CDK2 activity

Journal of General Virology

Volumn 93, Issue 1, 2012, Pages 139-149

  Huang, Sheng Yen ^a,b,c   Hsieh, Min Jie ^a   Chen, Chu Ying ^a   Chen, Yen Ju ^a   Chen, Jen Yang ^a,b,c   Chen, Mei Ru ^a   Tsai, Ching Hwa ^a   Lin, Su Fang ^c   Hsu, Tsuey Ying ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; LUCIFERASE; PROTEIN P21; PROTEIN P53; RTA PROTEIN; STRATIFIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL POPULATION; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HEP 2 CELL; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; UPREGULATION;

14-3-3 PROTEINS; CELL CYCLE CHECKPOINTS; CELL LINE; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; EPSTEIN-BARR VIRUS INFECTIONS; G1 PHASE; HERPESVIRUS 4, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; S PHASE; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 83755183735     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.034405-0     Document Type: Article

References (56)

1. Adamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J. & Kenney, S. (2000). Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J Virol 74, 1224-1233.
2. Arvanitakis, L., Yaseen, N. & Sharma, S. (1995). Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-b1-mediated growth inhibition in EBV-positive B cells. J Immunol 155, 1047-1056.
3. Blagosklonny, M. V. (2006). Cell senescence: hypertrophic arrest beyond the restriction point. J Cell Physiol 209, 592-597.
4. Cayrol, C. & Flemington, E. K. (1996). The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J 15, 2748-2759.
5. Chang, L. K., Chung, J. Y., Hong, Y. R., Ichimura, T., Nakao, M. & Liu, S. T. (2005). Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res 33, 6528-6539.
6. Chen, Y.-L., Chen, Y.-J., Tsai, W.-H., Ko, Y.-C., Chen, J.-Y. & Lin, S.-F. (2009). The Epstein-Barr virus replication and transcription activator, Rta/BRLF1, induces cellular senescence in epithelial cells. Cell Cycle 8, 58-65.
7. Chen, Y. J., Tsai, W. H., Chen, Y. L., Ko, Y. C., Chou, S. P., Chen, J. Y. & Lin, S. F. (2011). Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells. PLoS ONE 6, e17809.
8. Countryman, J. & Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A 82, 4085-4089.
9. Crawford, D. H., Epstein, M. A., Bornkamm, G. W., Achong, B. G., Finerty, S. & Thompson, J. L. (1979). Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas. Int J Cancer 24, 294-302.
10. Crook, T., Nicholls, J. M., Brooks, L., O'Nions, J. & Allday, M. J. (2000). High level expression of DN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19, 3439-3444.
11. Darr, C. D., Mauser, A. & Kenney, S. (2001). Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J Virol 75, 6135-6142.
12. de Bruyn Kops, A. & Knipe, D. M. (1988). Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein. Cell 55, 857-868.
13. DiMaio, D. & Coen, D. M. (2001). Replication strategies of DNA viruses. In Fields Virology, 3rd edn, pp. 119-132. Edited by D. M. Knipe. Philadelphia, PA: Lippincott Williams & Wilkins.
14. Ehmann, G. L., McLean, T. I. & Bachenheimer, S. L. (2000). Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells. Virology 267, 335-349.
15. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. & Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
16. Epstein, M. A., Achong, B. G. & Barr, Y. M. (1964). Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1, 702-703.
17. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. & Delecluse, H. J. (2000). The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19, 3080-3089.
18. Feederle, R., Neuhierl, B., Bannert, H., Geletneky, K., Shannon-Lowe, C. & Delecluse, H. J. (2007). Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer 121, 588-594.
19. Feng, P., Ren, E. C., Liu, D., Chan, S. H. & Hu, H. (2000). Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis. J Gen Virol 81, 2417-2423.
20. Flemington, E. K. (2001). Herpesvirus lytic replication and the cell cycle: arresting new developments. J Virol 75, 4475-4481.
21. Gao, Z., Krithivas, A., Finan, J. E., Semmes, O. J., Zhou, S., Wang, Y. & Hayward, S. D. (1998). The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins. J Virol 72, 8559-8567.
22. Gruffat, H. & Sergeant, A. (1994). Characterization of the DNAbinding site repertoire for the Epstein-Barr virus transcription factor R. Nucleic Acids Res 22, 1172-1178.
23. Guo, Q., Qian, L., Guo, L., Shi, M., Chen, C., Lv, X., Yu, M., Hu, M., Jiang, G. & Guo, N. (2010). Transactivators Zta and Rta of Epstein- Barr virus promote G0/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle. Mol Immunol 47, 1783-1792.
24. Henle, G. & Henle, W. (1976). Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17, 1-7.
25. Hermeking, H., Lengauer, C., Polyak, K., He, T. C., Zhang, L., Thiagalingam, S., Kinzler, K. W. & Vogelstein, B. (1997). 14-3-3s is a p53-regulated inhibitor of G2/M progression. Mol Cell 1, 3-11.
26. Hiscott, J. B. & Defendi, V. (1979). Simian virus 40 gene A regulation of cellular DNA synthesis. I. In permissive cells. J Virol 30, 590-599.
27. Hobbs, W. E., II & DeLuca, N. A. (1999). Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J Virol 73, 8245-8255.
28. Hsu, T. Y., Chang, Y., Wang, P. W., Liu, M. Y., Chen, M. R., Chen, J. Y. & Tsai, C. H. (2005). Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal. J Gen Virol 86, 317-322.
29. Imai, S., Koizumi, S., Sugiura, M., Tokunaga, M., Uemura, Y., Yamamoto, N., Tanaka, S., Sato, E. & Osato, T. (1994). Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein- Barr virus latent infection protein. Proc Natl Acad Sci U S A 91, 9131-9135.
30. Kudoh, A., Fujita, M., Kiyono, T., Kuzushima, K., Sugaya, Y., Izuta, S., Nishiyama, Y. & Tsurumi, T. (2003). Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J Virol 77, 851-861.
31. Lee, Y. H., Chiu, Y. F., Wang, W. H., Chang, L. K. & Liu, S. T. (2008). Activation of the ERK signal transduction pathway by Epstein-Barr virus immediate-early protein Rta. J Gen Virol 89, 2437-2446.
32. Li, Y., Webster-Cyriaque, J., Tomlinson, C. C., Yohe, M. & Kenney, S. (2004a). Fatty acid synthase expression is induced by the Epstein- Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. J Virol 78, 4197-4206.
33. Li, Y., Mahajan, N. P., Webster-Cyriaque, J., Bhende, P., Hong, G. K., Earp, H. S. & Kenney, S. (2004b). The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1. J Virol 78, 11778-11785.
34. Makarova, O., Kamberov, E. & Margolis, B. (2000). Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques 29, 970-972.
35. Mauser, A., Holley-Guthrie, E., Zanation, A., Yarborough, W., Kaufmann, W., Klingelhutz, A., Seaman, W. T. & Kenney, S. (2002). The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J Virol 76, 12543-12552.
36. Niedobitek, G. & Young, L. S. (1994). Epstein-Barr virus persistence and virus-associated tumours. Lancet 343, 333-335.
37. Noris, E., Zannetti, C., Demurtas, A., Sinclair, J., De Andrea, M., Gariglio, M. & Landolfo, S. (2002). Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence. J Virol 76, 12135-12148.
38. Op De Beeck, A. & Caillet-Fauquet, P. (1997). Viruses and the cell cycle. Prog Cell Cycle Res 3, 1-19.
39. Parker, G. A., Touitou, R. & Allday, M. J. (2000). Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis. Oncogene 19, 700-709.
40. Petrik, D. T., Schmitt, K. P. & Stinski, M. F. (2006). Inhibition of cellular DNA synthesis by the human cytomegalovirus IE86 protein is necessary for efficient virus replication. J Virol 80, 3872-3883.
41. Ragoczy, T. & Miller, G. (2001). Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J Virol 75, 5240-5251.
42. Ragoczy, T., Heston, L. & Miller, G. (1998). The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol 72, 7978-7984.
43. Rodriguez, A., Jung, E. J. & Flemington, E. K. (2001). Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents. J Virol 75, 4482-4489.
44. Sanchez, V. & Spector, D. H. (2008). Subversion of cell cycle regulatory pathways. Curr Top Microbiol Immunol 325, 243-262.
45. Sato, Y. & Tsurumi, T. (2010). Noise cancellation: viral fine tuning of the cellular environment for its own genome replication. PLoS Pathog 6, e1001158.
46. Sinclair, A. J., Palmero, I., Peters, G. & Farrell, P. J. (1994). EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J 13, 3321-3328.
47. Sun, C. C. & Thorley-Lawson, D. A. (2007). Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein- Barr virus BZLF1 promoter. J Virol 81, 13566-13577.
48. Swenson, J. J., Mauser, A. E., Kaufmann, W. K. & Kenney, S. C. (1999). The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J Virol 73, 6540-6550.
49. Takada, K. (1984). Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33, 27-32.
50. Tao, Q., Srivastava, G., Chan, A. C. & Ho, F. C. (1995). Epstein-Barrvirus- infected nasopharyngeal intraepithelial lymphocytes. Lancet 345, 1309-1310.
51. Vereide, D. T. & Sugden, B. (2011). Lymphomas differ in their dependence on Epstein-Barr virus. Blood 117, 1977-1985.
52. Wiebusch, L. & Hagemeier, C. (2001). The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation. EMBO J 20, 1086-1098.
53. Wu, F. Y., Chen, H., Wang, S. E., ApRhys, C. M., Liao, G., Fujimuro, M., Farrell, C. J., Huang, J., Hayward, S. D. & Hayward, G. S. (2003). CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle. J Virol 77, 1481-1500.
54. Zalani, S., Holley-Guthrie, E. & Kenney, S. (1996). Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci U S A 93, 9194-9199.
55. zur Hausen, H., O'Neill, F. J., Freese, U. K. & Hecker, E. (1978). Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272, 373-375.
56. Zydek, M., Hagemeier, C. & Wiebusch, L. (2010). Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog 6, e1001096.